141 related articles for article (PubMed ID: 26716564)
1. Current role of local treatments for erectile dysfunction in the real-life setting.
Moisidis K; Kalinderis N; Hatzimouratidis K
Curr Opin Urol; 2016 Mar; 26(2):123-8. PubMed ID: 26716564
[TBL] [Abstract][Full Text] [Related]
2. Intraurethral alprostadil for erectile dysfunction: a review of the literature.
Costa P; Potempa AJ
Drugs; 2012 Dec; 72(17):2243-54. PubMed ID: 23170913
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
Hatzimouratidis K; Salonia A; Adaikan G; Buvat J; Carrier S; El-Meliegy A; McCullough A; Torres LO; Khera M
J Sex Med; 2016 Apr; 13(4):465-88. PubMed ID: 27045254
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
5. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
Bodner DR; Haas CA; Krueger B; Seftel AD
Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
[TBL] [Abstract][Full Text] [Related]
6. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
7. [Transurethral alprostadil (MUSE) in erectile dysfunction].
Comeri G; Gianneo E; Nespoli R
Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
[TBL] [Abstract][Full Text] [Related]
8. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction.
Rooney M; Pfister W; Mahoney M; Nelson M; Yeager J; Steidle C
J Sex Med; 2009 Feb; 6(2):520-34. PubMed ID: 19138370
[TBL] [Abstract][Full Text] [Related]
9. An update on the drug safety of treating erectile dysfunction.
Gul M; Serefoglu EC
Expert Opin Drug Saf; 2019 Oct; 18(10):965-975. PubMed ID: 31433252
[No Abstract] [Full Text] [Related]
10. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.
Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I
Urology; 2000 Jan; 55(1):109-13. PubMed ID: 10654905
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.
Padma-Nathan H; Steidle C; Salem S; Tayse N; Yeager J; Harning R
Int J Impot Res; 2003 Feb; 15(1):10-7. PubMed ID: 12605235
[TBL] [Abstract][Full Text] [Related]
12. Current status of local penile therapy.
Montorsi F; Salonia A; Zanoni M; Pompa P; Cestari A; Guazzoni G; Barbieri L; Rigatti P
Int J Impot Res; 2002 Feb; 14 Suppl 1():S70-81. PubMed ID: 11850739
[TBL] [Abstract][Full Text] [Related]
13. Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program.
Steidle C; Padma-Nathan H; Salem S; Tayse N; Thwing D; Fendl J; Yeager J; Harning R
Urology; 2002 Dec; 60(6):1077-82. PubMed ID: 12475674
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil.
Moncada I; Martinez-Salamanca J; Ruiz-Castañe E; Romero J
Int J Impot Res; 2018 Oct; 30(5):203-208. PubMed ID: 30050072
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of Vitaros©/Virirec© (Alprostadil cream) for the treatment of erectile dysfunction.
Moncada I; Cuzin B
Urologia; 2015; 82(2):84-92. PubMed ID: 25744707
[TBL] [Abstract][Full Text] [Related]
16. An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients.
Padma-Nathan H; Yeager JL
Urology; 2006 Aug; 68(2):386-91. PubMed ID: 16904458
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.
Williams G; Abbou CC; Amar ET; Desvaux P; Flam TA; Lycklama à Nijeholt GA; Lynch SF; Morgan RJ; Müller SC; Porst H; Pryor JP; Ryan P; Witzsch UK; Hall MM; Place VA; Spivack AP; Gesundheit N
Br J Urol; 1998 Jun; 81(6):889-94. PubMed ID: 9666777
[TBL] [Abstract][Full Text] [Related]
18. Does alprostadil cream hit the spot?
Drug Ther Bull; 2015 Feb; 53(2):21-4. PubMed ID: 25678352
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil.
Hellstrom WJ; Bennett AH; Gesundheit N; Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC; Place VA
Urology; 1996 Dec; 48(6):851-6. PubMed ID: 8973666
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails.
Lee M; Sharifi R
Drugs Aging; 2018 Mar; 35(3):175-187. PubMed ID: 29464656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
